Navigation Links
Funding for neglected global diseases research at UBC exceeds $20 million
Date:9/9/2012

Researchers with the Neglected Global Diseases Initiative (NGDI) at the University of British Columbia have attracted more than $20 million in funding to find ways to eliminate diseases and conditions that kill millions of people in developing countries worldwide.

Launched in 2009, the NGDI brings together top UBC researchers to study and develop treatment for infectious diseases of poverty, including HIV/AIDS, tuberculosis and malaria. Their work includes basic understanding of these diseases, vaccine and drug development, health care infrastructure and food security.

"As a whole, neglected global diseases affect one billion people worldwide and approximately 8.7 million die from them each year," says Kishor Wasan, NGDI director and a professor in the Faculty of Pharmaceutical Sciences. "But compared to other diseases such as diabetes or heart disease they receive relatively little research funding."

The Bill & Melinda Gates Foundation ($7M), the Canadian International Development Agency ($6.8M in conjunction with the International Development Research Centre and the National Research Council of Canada) and the Canadian Institutes of Health Research ($6.6M) make up the bulk of neglected global diseases research funding at UBC.

In 2010, global investment in research and development in the area of neglected global diseases totaled just over $3 billion, more than half of it towards HIV and TB and $547M towards malaria.

Twelve funders provide almost 90 per cent of this overall investment, with the U.S. National Institutes of Health as the top funder at $1.2 billion, pharmaceutical and biotechnology companies at $503 million and Bill & Melinda Gates Foundation at $455 million.

Funded projects at UBC include $7 million from the Bill & Melinda Foundation towards research on pre-eclampsia, a high blood pressure disorder that is the second leading cause of maternal death worldwide; $4.9 million towards nutrition related studies and $4.6 million towards the treatment and prevention of HIV/ADIS and tuberculosis.


'/>"/>

Contact: Kishor Wasan
kishor.wasan@ubc.ca
604-454-4864
University of British Columbia
Source:Eurekalert

Related medicine news :

1. UCLA Brain Injury Research Center gets NCAA funding for research on sports concussions
2. Study reveals major funding shortfall and high death rates for emergency laparotomy
3. New study of NIH funding allocations suggests potential efficiency gains
4. Canada should significantly increase its funding of randomized clinical trials
5. UCI stem cell researcher to receive $4.8 million in state funding
6. UC San Diego researchers receive new CIRM funding
7. 29 Johns Hopkins stem cell researchers awarded funding
8. Save the Children report shows global health funding often ignores newborn babies
9. Aging Brain Care model receives $7.8 million in CMS innovation funding
10. Funding for teacher classroom management study
11. Louisiana Tech biomedical engineering professor earns recognition, funding for research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... KS (PRWEB) , ... June 27, 2016 , ... TopConsumerReviews.com ... retailers of Eyeglasses . , Millions of individuals in the United States and ... have become a way to both correct vision and make a fashion statement. Even ...
(Date:6/26/2016)... ... ... PawPaws brand pet supplements owned by Whole Health Supply is ... of felines. The formula is all-natural and is made from Chinese herbs that have ... Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root Extract ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... Austin ... of the American College of Mohs Surgery and to Dr. Russell Peckham for medical ... and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... As a ... Magna Cum Laude and his M.D from the David Geffen School of Medicine at ... returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars ...
(Date:6/24/2016)... Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... surgery procedures that most people are unfamiliar with. The article goes on to state ... procedures, but also many of these less common operations such as calf and cheek ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 Research and ... Market for Companion Diagnostic Tests" report to their offering. ... for Companion Diagnostics The World Market for ... personalized medicine diagnostics. Market analysis in the report includes the ... Market (In Vitro Diagnostic Kits) by Region (N. America, EU, ...
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... Research and Markets has announced the addition ... Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, Binder, ... Forecast to 2021" report to their offering. ... excipients market is projected to reach USD 8.1 Billion ... forecast period 2016 to 2021. The ...
Breaking Medicine Technology: